“Purdue Pharma Sentencing Delayed to Amplify Victim Voices in Opioid Crisis Reckoning | Nov” — what this page in the network covers. The sentencing for Purdue Pharma, the maker of OxyContin, has been unexpectedly delayed by a federal judge, offering a critical opportunity for victims of... The sentencing for Purdue Pharma, the maker of OxyContin, has been unexpectedly delayed by a federal judge, offering a critical opportunity for victims of the opioid crisis to directly share their experiences.
This pause in the proceedings, originally set to finalize a $225 million forfeiture to the Justice Department as part of a bankruptcy settlement, underscores a judicial commitment to acknowledging the profound human impact of the opioid epidemic. While this delay may prolong the pursuit of resolution, it represents a significant step toward ensuring that the devastating consequences of Purdue Pharma's marketing practices are heard and considered within the justice system. For the complete material, the listing points back to the source inside the network.